Browse Related Topics For:

Patents

3221
Patent Litigation
2479
Patent Infringement
1277
USPTO
1110
Patent Trial and Appeal Board
1084
Inter Partes Review (IPR) Proceeding
1057
Patent-Eligible Subject Matter
950
SCOTUS
842
Pharmaceutical Industry
715
Pharmaceutical Patents
613
Claim Construction
595
America Invents Act
554
Appeals
526
Patent Applications
506
Prior Art
504
CLS Bank v Alice Corp
485
Popular
362
Patent Reform
343
Obviousness
332
Infringement
300
Section 101
292
Generic Drugs
288
Patent Invalidity
272
Covered Business Method Patents
272
Trademarks
267
Software
259
Biotechnology
258
ANDA
248
FDA
246
Abstract Ideas
243
Prescription Drugs
242
Copyright
235
Post-Grant Review
230
Mayo v. Prometheus
222
EU
221
Myriad
221
Patent Trolls
219
DNA
209
ITC
205
Induced Infringement
203
Design Patent
191
Intellectual Property Protection
179
Trade Secrets
177
Patent-in-Suit
173
AMP v Myriad
173
Hatch-Waxman
166
Biosimilars
163
FTC
159
Corporate Counsel
157
Covered Business Method Proceedings
155
Summary Judgment
152
Attorney's Fees
151
Patent Ownership
148
Inventors
146
Apple
145
Computer-Related Inventions
144
BPCIA
139
Discovery
134
Australia
133
Human Genes
129
Young Lawyers
124
Technology
123
Octane Fitness v. ICON
122
Life Sciences
119
Standard Essential Patents
116
Indefiniteness
112
En Banc Review
112
Willful Infringement
111
IP License
109
Inventions
107
License Agreements
107
Patent Royalties
106
Medical Devices
103
Evidence
102
First-to-File
100
Damages
98
Alice Corporation
98
Motion to Dismiss
96
Software Patents
94
FRAND
94
Jurisdiction
94
Standing
93
Amgen
93
Intellectual Property Litigation
93
Reversal
93
Sandoz
92
CLS Bank
92
Royalties
92
Standard of Review
91
Teva Pharmaceuticals
89
Expert Testimony
89
Genetic Materials
87
Broadest Reasonable Interpretation Standard
87
Samsung
85
Declaratory Judgments
85
Federal Rules of Civil Procedure
84
Motion to Amend
84
Nautilus Inc. v. Biosig Instruments
84
Non-Practicing Entities
84
Preliminary Injunctions
83
Patent Term Adjustment
83
Teva v Sandoz
82
Direct Infringement
80
Sandoz v Amgen
78
China
77
Manufacturers
77
Patent Prosecution
76
Apple v Samsung
74
Actavis Inc.
74
De Novo Standard of Review
73
Microsoft
72
Licenses
71
Halo v Pulse
71
UK
69
Biologics
69
Section 337
69
Utility Patents
68
Google
67
Enhanced Damages
67
Myriad-Mayo
66
Estoppel
66
Limelight v Akamai
65
Reverse Payment Settlement Agreements
64
Apotex
64
Innovation Act
63
Cisco v CommilUSA
63
Motion To Stay
63
Patent Exhaustion
62
Clear Error Standard
61
FTC v Actavis
61
Highmark v. Allcare
60
Remand
59
Akamai Technologies
59
Petition For Rehearing
58
Healthcare
57
Antitrust Litigation
57
Good Faith
57
Novartis
55
Injunctions
55
Joinder
55
Patent Filings
54
Administrative Proceedings
54
Certiorari
54
First-to-Invent
54
Proposed Legislation
53
Kimble v Marvel Enterprises
52
European Patent Office
52
Sequenom
51
Expert Witness
51
Product of Nature Doctrine
50
Imports
50
Real Party in Interest
50
Unified Patent Court
49
Burden of Proof
49
DOJ
49
Markman Hearing
49
Medtronic
49
Mylan Pharmaceuticals
48
Startups
47
Canada
47
Copyright Infringement
47
Exceptional Case
47
Innovation
47
Patent Examinations
47
Pay-For-Delay
47
Settlement
46
Limelight Networks
46
Misappropriation
46
Patent Dance
46
Personal Jurisdiction
46
Unitary Patent
45
Cisco
45
Judicial Review
45
Smartphones
44
Inter Partes Reexamination
44
Preemption
43
EPO
43
Motorola
43
Patent Assertion Entities
42
35 U.S.C. § 284
42
AstraZeneca
42
Cuozzo Speed Technologies
42
Risk Mitigation
42
Vacated
42
Written Descriptions
41
Bilski
41
Guidance Update
41
Noninfringement
40
Confidential Information
40
Ex Partes Reexamination
40
Notice Requirements
40
Preponderance of the Evidence
40
Request for Continued Examination
39
Administrative Procedure Act
39
BRCA
39
Dismissals
39
European Court of Justice (ECJ)
39
Patent Cooperation Treaty
39
Pfizer
38
Laches
38
Pleading Standards
38
UK Brexit
37
Breach of Contract
37
Brulotte
37
Class Action
37
Means-Plus-Function
37
Sanctions
37
Stare Decisis
36
Depositions
36
Patent Validity
36
Petition for Writ of Certiorari
35
CAFC
35
Competition
35
Eli Lilly
35
Genetically Engineered Seed
35
Inequitable Conduct
35
On-Sale Bar
35
Patent Portfolios
35
Pleadings
35
Public Comment
35
Seagate
35
Sherman Act
34
Abuse of Discretion
34
Commercial Marketing
34
Software Developers
34
USPTO Pilot Program
33
Abuse of Process
33
Arbitration
33
Cuozzo Speed Technologies v Lee
33
FDA Approval
33
Validity
33
Watson Pharmaceuticals
32
Final Judgment
32
Lanham Act
32
Monsanto
31
Article III
31
Attorney-Client Privilege
31
Bad Faith
31
Disclosure Requirements
31
Indirect Infringement
31
Merck
31
Safe Harbors
31
Venue
30
Diagnostic Method
30
Japan
30
Judicial Discretion
30
Method Claims
29
Advertising
29
Bowman v Monsanto
29
Divided Infringement
29
Hart-Scott-Rodino Act
29
Honest Belief Defense
29
Universities
28
Enfish v Microsoft
28
Fee-Shifting
28
Genetic Testing
28
Hague Agreement
28
Kappos
28
Mobile Devices
28
PATENT Act
28
Stem cells
28
Stryker v Zimmer
28
Trademark Registration
27
Automotive Industry
27
Doctrine of Equivalents
27
Injunctive Relief
27
Legislative Agendas
27
Limelight
27
Patent Terms
27
Subject Matter Jurisdiction
27
WIPO
26
Chevron Deference
26
Examiners
26
Statute of Limitations
25
ALJ
25
Amicus Briefs
25
Counterclaims
25
First Amendment
25
Gene Patenting
25
Internet
25
Oral Argument
25
Ultramercial v Hulu
24
Allergan Inc
24
Foreign Patent Applications
24
Frivolous Lawsuits
24
Orange Book
24
Pending Legislation
24
Standard of Proof
24
Suprema
24
The Copyright Act
24
Trade Dress
23
ACLU
23
Antitrust Provisions
23
Australian Patent Office
23
Cell Phones
23
Enforcement
23
Hedge Funds
23
Hospira
23
Litigation Strategies
23
Rule 11
23
Unfair Competition
22
3D Printing
22
Brooks Furniture
22
Data Protection
22
First Sale Doctrine
22
Gilead Sciences
22
New Legislation
22
Patent Owner Preliminary Response
22
Patent Prosecution Highway
22
Stays
22
Trademark Infringement
21
Collateral Estoppel
21
European Commission
21
IP Assignment Agreements
21
Jury Verdicts
21
Motion for Summary Judgment
21
Motion To Strike
21
Non-Appealable Decisions
21
Permanent Injunctions
21
RAND
21
Technology Sector
20
Acquisitions
20
Calculation of Damages
20
Comment Period
20
Filing Deadlines
20
Foreign Investment
20
Functionality
20
Industrial Design
20
Judgment on the Pleadings
20
Patent Expiration
20
Proposed Amendments
20
Reissue Patents
20
Twombly/Iqbal Pleading Standard
19
Anti-Competitive
19
Antitrust Violations
19
Barack Obama
19
Cybersecurity
19
Diagnostic Tests
19
Germany
19
GlaxoSmithKline
19
Interim Guidance
19
iPhone
19
Joint Infringement
19
Licensing Rules
19
Non-Disclosure Agreement
19
Oil & Gas
19
Qualcomm
19
Research and Development
19
Trans-Pacific Partnership
18
Bascom Global v AT&T Mobility
18
Biologics Price Competition and Innovation Act of 2009
18
Business Assets
18
Cancer
18
Defend Trade Secrets Act (DTSA)
18
Definiteness
18
Disparagement
18
Due Process
18
Federal Register
18
Interference Proceeding
18
Kirtsaeng v. John Wiley & Sons
18
Mootness
18
New Guidance
18
Petrella v. MGM
18
Protective Orders
18
Provisional Applications
18
Referendums
17
Attorney Malpractice
17
Contract Term
17
Derivation Proceeding
17
Fashion Industry
17
Genentech
17
Issue Preclusion
17
Member State
17
Monopolization
17
Par Pharmaceutical
17
Personalized Medicine
17
SEC
17
Seeds
17
Tariff Act of 1930
17
Transfer of Venue
17
TRIPS Agreement
16
Ambry
16
Bayh-Dole Act
16
Bristol-Myers Squibb
16
Clean Tech
16
Due Diligence
16
Enablement Inquiries
16
Entrepreneurs
16
European Patent Convention
16
Extraterritoriality Rules
16
Facebook
16
Forum Selection
16
Medtronic v Boston Scientific
16
Motion to Compel
16
Prevailing Party
16
Takeda Pharmaceuticals
16
Telecommunications
16
Testimony
15
aBLA
15
Additional Discovery
15
Amazon
15
Ariosa
15
Auto Manufacturers
15
Bayer
15
Brand
15
Contributory Infringement
15
Declaration
15
Disclosure
15
Document Productions
15
Exclusion Orders
15
Federal Rule 12(b)(6)
15
Ford Motor
15
Forum Shopping
15
JMOL
15
Lexmark
15
Marketing
15
Myriad v Ambry
15
Sprint
15
The Patent Act
15
Trademark Litigation
15
Unfair or Deceptive Trade Practices
15
Venture Capital
15
Websites
15
WTO
14
Allergan v Sandoz
14
Commercial Bankruptcy
14
Customs
14
DMCA
14
eBay
14
Endo Pharmaceuticals
14
Enforcement Actions
14
Foreign Corporations
14
Generic
14
Jury Trial
14
Legal Perspectives
14
Mergers
14
Nintendo
14
Prior User
14
PTO
14
Settlement Agreements
14
Small Business
14
The Patent Box
14
Trademark Trial and Appeal Board
14
Uniform Commercial Code (UCC)
13
AbbVie
13
Abuse of Dominance
13
Ambiguous
13
Animation
13
Cephalon
13
Confidentiality Agreements
13
Cross Examination
13
Cross-Border
13
Dispute Resolution
13
Energy Sector
13
False Advertising
13
Fees
13
Final Rules
13
Interlocutory Appeals
13
International Arbitration
13
Investors
13
Irreparable Harm
13
Judgment As A Matter Of Law
13
LG Electronics
13
Likelihood of Confusion
13
Micro Entity Status
13
New Zealand
13
Plant Patents
13
Proposed Regulation
13
Roxane Laboratories
13
Social Media
13
STRONG Patents Act
13
Third-Party
13
Treble Damages
13
Uniform Trade Secrets Acts
12
AFCP
12
Assignment of Inventions
12
AT&T Mobility
12
Component Parts Doctrine
12
Corporate Taxes
12
Counterfeiting
12
Daubert Standards
12
Equitable Estoppel
12
Exports
12
Fast Track Process
12
Filing Fees
12
Free Speech
12
IEEE
12
Innovation Patent
12
Investigations
12
Miniauction
12
Mobile Apps
12
Nokia
12
Patent Fees
12
Scope of the Claim
12
SSO
12
Sua Sponte
12
Supplemental Examination
12
Wireless Technology
11
Article of Manufacture
11
Assignments
11
Biopharmaceutical
11
Compliance
11
Dell
11
Demand Letter
11
Divisional Applications
11
E-Commerce
11
Electronics
11
Employment Contract
11
Expiration Date
11
Extrinsic Evidence
11
Farms
11
Federal Jurisdiction
11
Federal Pilot Programs
11
Fraud
11
Garmin International
11
General Electric
11
Gunn v Minton
11
Inventive Concept Test
11
Italy
11
Janssen Pharmaceuticals
11
Legislative Committees
11
Marvel Comics
11
Motions in Limine
11
Nanotechnology
11
Order to Stay
11
Patent Agent Privilege
11
Patent Amendments
11
Patent Oppositions
11
Patentability Search
11
Petitions for Review
11
Pre-GATT
11
Public Disclosure
11
Public Use
11
Right of Publicity
11
SAP America Inc.
11
Substantial Evidence Standard
11
Supplemental Evidence
11
Suppliers
11
TC Heartland LLC v Kraft Foods
11
Versata
11
Video Games
11
Writ of Mandamus
10
Antitrust Investigations
10
Assignor Estoppel
10
Claim Preclusion
10
Domestic Industry Requirement
10
Double Patent
10
Failure To State A Claim
10
Fair Use
10
Fashion Design
10
FDCA
10
Fresenius
10
Highmark
10
Holidays
10
IPO
10
Licensing Rights
10
Litigation Fees & Costs
10
Lost Profits
10
Mediation
10
Medical Research
10
Motion for Reconsideration
10
Physicians
10
Privity of Contract
10
Public Interest
10
Reaffirmation
10
Registration
10
Res Judicata
10
Reviewability Determinations
10
Rulemaking Process
10
Symantec
10
Totality of Circumstances Test
10
Transparency
10
Work Product Privilege
9
Affirmative Defenses
9
Affordable Care Act
9
Algorithms
9
Amended Complaints
9
Anti-Dumping Duty
9
Applications
9
Arbitration Agreements
9
Barnes and Noble
9
Cease and Desist
9
Chemicals
9
Cloud Computing
9
Covenant Not to Sue
9
Customs and Border Protection
9
Data Collection
9
Domain Names
9
Duty of Candor
9
Electronic Data Transmissions
9
FCPA
9
Foreign Jurisdictions
9
Hana Financial v Hana Bank
9
IBM
9
Indemnification
9
Information Disclosure Statement
9
Injury-in-Fact
9
International Litigation
9
Joint Venture
9
JPO
9
Jury Awards
9
Motion for Judgment
9
Motion for Sanctions
9
MPEP
9
New Trial
9
Oracle
9
Patent Law Treaty
9
PHRMA
9
Presumption of Validity
9
Profits
9
Remedies
9
Rule-of-Reason Analysis
9
Salesforce
9
Split of Authority
9
Subsidiaries
9
Supplementary Protection Certificate
9
Terminal Disclaimer
9
Transfers
9
Twitter
9
USTR
8
Abbott Laboratories
8
Adobe
8
Anti-Monopoly
8
B&B Hardware v Hargis Industries
8
Burden of Production
8
Burden-Shifting
8
Cartels
8
Case Consolidation
8
Classen Immunotherapies
8
Clinical Trials
8
Community Designs
8
Contract Terms
8
Cross-Licensing Agreement
8
Cybor Corp v FAS Technologies
8
DaimlerChrysler v Bauman
8
Defense Strategies
8
Dow Chemical
8
Draft Guidance
8
Ericsson
8
Ex Parte
8
Exclusions
8
False Claims Act (FCA)
8
Federal Contractors
8
Filing Requirements
8
Food Manufacturers
8
Form 18
8
GMO
8
gTLD
8
Hewlett-Packard
8
Hospitals
8
HTC
8
Intel
8
JPMorgan Chase
8
Misrepresentation
8
Music
8
OECD
8
Premerger Notifications
8
Price-Fixing
8
Priority Patent Claims
8
Private Right of Action
8
Prometheus
8
Retailers
8
RICO
8
Sanofi-Aventis
8
Solicitor General
8
Sovereign Immunity
8
Tacking
8
Theft
8
Tortious Interference
8
Toyota
8
Trade Agreements
8
UTSA
8
Walker Process Claims
8
Wearable Technology
8
Wyeth
7
ACIP
7
Anticompetitive Agreements
7
AOL
7
Banks
7
Blackberry
7
Brazil
7
Burden of Persuasion
7
Comcast
7
Commercial General Liability Policies
7
Compulsory Licenses
7
Conflicts of Interest
7
Contract Interpretation
7
Copyright Office
7
Countervailing Duties
7
Criminal Prosecution
7
Databases
7
DDR Holdings v Hotels.com
7
Economic Espionage Act
7
Eleventh Amendment
7
Email
7
Energy
7
Enhanced Penalties
7
Fair Market Value
7
Federal Rules of Evidence
7
Fiduciary Duty
7
Final Action
7
Food Labeling
7
Foreign Sales
7
Genzyme
7
Grace Period
7
Health Care Providers
7
Health Insurance
7
India
7
Inherency
7
Inherent Disclosure Doctrine
7
Intellectual Property Owners Association
7
International Harmonization
7
Internet Service Providers (ISPs)
7
Mandamus Petitions
7
MOFCOM
7
Motion to Exclude
7
Motion to Transfer
7
NAFTA
7
NIH
7
Nike
7
Obama Administration
7
Objective Unreasonableness Standard
7
OTDP
7
PLTIA
7
Principal Place of Business
7
Product Exclusivity
7
Putative Class Actions
7
Raising The Bar Act
7
Ratification
7
Reasonable Certainty Standard
7
Securities Fraud
7
SIPO
7
Sony
7
Subject Matter Experts
7
Supplemental Information
7
Supply Chain
7
Target
7
Tariffs
7
Technology Transfer Agreements
7
Tesla
7
The Clayton Act
7
Toshiba
7
Treatment Method Patents
7
Trump Administration
7
U.S. Commerce Department
7
Unjust Enrichment
7
USDA
7
Warner Chilcott
7
Webinars
7
WildTangent v Ultramercial
7
YouTube
6
AIPLA
6
Airlines
6
Alien Tort Statute
6
Anticipation
6
Apportionment
6
Article 50 Treaty of the EU
6
Asset Seizure
6
Audits
6
BEPS
6
Bifurcation
6
Biofuel
6
Biogen Idec
6
Canadian Intellectual Property Office
6
Cease and Desist Orders
6
Clear and Convincing Evidence
6
Collaboration
6
Competition Authorities
6
Computer Fraud and Abuse Act (CFAA)
6
Consent Order
6
Constitutional Challenges
6
Contempt
6
Coopertive Patent Classification System
6
Copyright Litigation
6
Deadlines
6
Digital Media
6
Drug Pricing
6
eBay Test
6
Effective Filing Date
6
Encryption
6
Entertainment Industry
6
Evidentiary Rulings
6
Federal Question Jurisdiction
6
Financial Products
6
Forward Publishing
6
GAO
6
Grable Factors
6
Hearsay
6
Hiring & Firing
6
HTC America
6
Hulu
6
Information Reports
6
Insider Trading
6
Internet Streaming
6
IPEC
6
Jazz Pharmaceuticals
6
Joint Inventors
6
Judge Rakoff
6
Judges
6
Jury Instructions
6
Kraft
6
Labeling
6
Legal History
6
Limitation Periods
6
Local Rules
6
Memorandum of Guidance
6
Multidistrict Litigation
6
Multinationals
6
Music Industry
6
New Regulations
6
Nexium
6
NLRB
6
Noerr-Pennington Doctrine
6
Online Gaming
6
Otsuka Pharmaceutical
6
Printed Publications
6
Privacy Laws
6
Rebuttable Presumptions
6
Redskins
6
Renewable Energy
6
Resales Agreements
6
Reverse Payments
6
Reversible Error
6
Right to a Jury
6
Roslin
6
Rule 26
6
Rules of Civil Procedure
6
Rules of Practice
6
Russia
6
Scienter
6
Securities
6
Seventh Amendment
6
Shire Development v Watson
6
South Korea
6
Star Athletica v Varsity Brands
6
Strategic Planning
6
Supreme Court of Canada
6
Tax Rates
6
Telemedicine
6
TFEU
6
Trials
6
Wireless Devices
5
Administrative Authority
5
Admissible Evidence
5
Agency Deference
5
Analogous Art
5
Antitrust Injuries
5
Artificial Intelligence
5
AT&T
5
Banking Sector
5
Bankruptcy Code
5
Best Practices
5
Bitcoin
5
Board of Directors
5
Boilerplate Language
5
Canon
5
Carnegie Mellon
5
CETA
5
Cheerleaders
5
Claim Amendments
5
Class Certification
5
Coca Cola
5
Common-Interest Privilege
5
Competition Act
5
Confidential Documents
5
Contract Disputes
5
COPPA
5
Cox Communications
5
Creditors
5
Cross-Border Transactions
5
Data Privacy
5
Deceptive Intent
5
Declaratory Relief
5
Defamation
5
Digital Goods
5
Disclaimers
5
Duty to Defend
5
Educational Institutions
5
EEA
5
Elan Pharmaceuticals
5
Elon Musk
5
Emerging Growth Companies
5
End-Users
5
Equitable Relief
5
European Union Intellectual Property Office (EUIPO)
5
Exclusive Licenses
5
Exclusivity
5
Exelixis
5
Expedited Actions Process
5
False Statements
5
Film Industry
5
Forum
5
Fracking
5
FTAIA
5
Gaming
5
Garmin Factors
5
Genuine Issue of Material Fact
5
Graham Factors
5
Graphical User Interface
5
Honda
5
Honeywell International
5
Hotels.com
5
ICANN
5
Information Technology
5
Insurance Industry
5
International Labor Laws
5
International Searching Authority
5
Internet of Things
5
IRS
5
Japan Patent Office
5
Keurig Inc
5
Law Matters
5
Leave to Amend
5
Legal Costs
5
Local Patent Rules
5
Malicious Prosecution
5
March-in
5
Motion To Reconsider
5
Motion to Terminate
5
Motion to Vacate
5
National Cancer Moonshot
5
Nunc Pro Tunc
5
Online Videos
5
Opt-Outs
5
Parent Corporation
5
Patent Term Extensions
5
Patent-Misuse
5
Penalties
5
Phillips Standard
5
Precedential Opinion
5
Prioritized Examination
5
Priority Date Cutoff
5
Proctor & Gamble
5
Product Labels
5
Professional Conferences
5
Quanta
5
RanBaxy
5
Reputational Injury
5
Restrictive Covenants
5
Risk Assessment
5
SCA Hygiene Products Aktiebolag v First Quality Baby Products
5
Scams
5
Section 271
5
Separation of Powers
5
Service of Process
5
Shareholder Litigation
5
Social Networks
5
Solar Energy
5
Sonos
5
Source Code
5
Spoliation
5
Sports
5
Standard Setting Organizations
5
Strategic Enforcement Plan
5
Sunrise Periods
5
Tax Incentives
5
Tax Reform
5
TD Ameritrade
5
Third-Party Relationships
5
Time Extensions
5
Trade Relations
5
TROL Act
5
TSA
5
Unified Patent System
5
Use in Commerce
5
Waivers
5
Whistleblower Protection Policies
5
Whistleblowers
5
White Collar Crimes
5
Work-For-Hire
4
23andMe
4
3-D Technology
4
Adidas
4
Administrative Patent Judges
4
Advertising Injury
4
Affidavits
4
Africa
4
Amended Regulation
4
Annual Reports
4
Anti-SLAPP
4
Anticompetitive Behavior
4
Antitrust Conspiracies
4
Antitrust Division
4
Arbitrary and Capricious
4
Bed Bath & Beyond
4
Big Data
4
Bilateral Investment Treaties
4
Broadcasting
4
Business Development
4
CAFA
4
Case Management
4
Certifications
4
Claim Charts
4
CMS
4
Co-Ownership
4
Collateral
4
Commercial Offer for Sale
4
Compensatory Damages
4
Consent Decrees
4
Consumer Bankruptcy
4
Continuation Applications